Cytori to Webcast Third Quarter Financial Results November 3
Prior to the webcast at approximately 4:05 PM Eastern Time on November 3, Cytori will issue its third quarter earnings release and post a quarterly shareholder letter to its Investor Relations homepage, which will review Cytori's third quarter performance.
The webcast will be available both live and by replay two hours after the call on the Company's website, under "Webcasts" on the Investor Relations page (http://ir.cytoritx.com).
Cytori Therapeutics, Inc.
Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft(TM) products are available in North America and Europe for fat grafting procedures. www.cytori.com